These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9358337)

  • 1. Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65.
    Schlosser M; Hahmann J; Ziegler B; Augstein P; Ziegler M
    J Immunoassay; 1997 Nov; 18(4):289-307. PubMed ID: 9358337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody based enzyme-linked immunosorbent assay for the determination of GAD65, the smaller isoform of glutamic acid decarboxylase.
    Hamann J; Hahmann J; Strebelow M; Ziegler B; Ziegler M
    Diabetes Res; 1994; 26(3):109-16. PubMed ID: 7621617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies specific to the glutamic acid decarboxylase 65 kDa isoform derived from a non-obese diabetic (NOD) mouse.
    Ziegler B; Augstein P; Lühder F; Northemann W; Hamann J; Schlosser M; Klöting I; Michaelis D; Ziegler M
    Diabetes Res; 1994; 25(2):47-64. PubMed ID: 7544254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the islet cell antibody pattern of monoclonal glutamic acid decarboxylase antibodies recognizing linear and conformational epitopes.
    Augstein P; Schlosser M; Ziegler B; Hahmann J; Mauch L; Ziegler M
    Acta Histochem; 1996 Apr; 98(2):229-41. PubMed ID: 8739307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions.
    Augstein P; Ziegler B; Schlosser M; Flassig S; Strebelow M; Ziegler M
    Pancreas; 1997 Aug; 15(2):139-46. PubMed ID: 9260198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays.
    Kotani R; Nagata M; Moriyama H; Nakayama M; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Yokono K
    Diabetes Care; 2002 Aug; 25(8):1390-7. PubMed ID: 12145240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a novel radioimmunoassay using 125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies.
    Marcovina SM; Landin-Olsson M; Essen-Möller A; Palmer JP; Lernmark A
    Int J Clin Lab Res; 2000; 30(1):21-6. PubMed ID: 10984128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant glutamic acid decarboxylase (representing the single isoform expressed in human islets) detects IDDM-associated 64,000-M(r) autoantibodies.
    Karlsen AE; Hagopian WA; Petersen JS; Boel E; Dyrberg T; Grubin CE; Michelsen BK; Madsen OD; Lernmark A
    Diabetes; 1992 Oct; 41(10):1355-9. PubMed ID: 1397711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
    Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
    Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.
    Aanstoot HJ; Kang SM; Kim J; Lindsay LA; Roll U; Knip M; Atkinson M; Mose-Larsen P; Fey S; Ludvigsson J; Landin L; Bruining J; Maclaren N; Akerblom HK; Baekkeskov S
    J Clin Invest; 1996 Jun; 97(12):2772-83. PubMed ID: 8675688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of glutamic acid decarboxylase (GAD65) in pancreatic islets and its in vitro and in vivo degradation kinetics in serum using a highly sensitive enzyme immunoassay.
    Schlosser M; Walschus U; Klöting I; Walther R
    Dis Markers; 2008; 24(3):191-8. PubMed ID: 18334741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.
    Rickert M; Seissler J; Dangel W; Lorenz H; Richter W
    Clin Chem; 2001 May; 47(5):926-34. PubMed ID: 11325898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.
    Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR
    Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species and epitope specificity of two 65 kDa glutamate decarboxylase time-resolved fluorometric immunoassays.
    Rui M; Hampe CS; Wang C; Ling Z; Gorus FK; Lernmark A; Pipeleers DG; De Pauw PE
    J Immunol Methods; 2007 Jan; 319(1-2):133-43. PubMed ID: 17210161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for glutamic acid decarboxylase-65.
    Hao W; Daniels T; Pipeleers DG; Smismans A; Reijonen H; Nepom GT; Lernmark A
    Diabetes Technol Ther; 1999; 1(1):13-20. PubMed ID: 11475299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.